There is currently a lot of controversy over the prerequisite of 'Incentive system for reducing pharmaceutical cost'

There is currently a lot of controversy over the prerequisite of 'Incentive system for reducing pharmaceutical cost' in order not to repeat the error of 'Incentive system for low price purchasing'.

First of all, it is pointed out that the price factor should not be included in Prescribing Costliness Index.

There is an opinion that medicines which have price reduction ahead in accordance with ...